New snacks on sale now for a limited time! Use code NEW for 15% off.

SEC Edgar and OTC Filings

SEC Filings

BioAdaptives®, Inc. (OTC BB: BDPT) complete regulatory filings are available on Edgar

Form 14-C - 2023 -3 - 9

Form 10-Q - 2022-11-14

Form 1-A POS - 2022-11-08

Form 1-A POS - 2022-10-28

Form 1-A POS 2022-10-07

Form 10-Q 2022-08-12

Form 8K, June 14, 2022

Form 253G1 May 16, 2022

Form 10-Q May,12, 2022

FORM 1-A/A, May 3, 2022

Form 10K, Mar, 31, 2022

1-A/A Mar 18, 2022

DEF 14C Mar, 15, 2022

FORM 1A Mar, 4 2022

FORM 8K  Feb, 3, 2022

FORM 14C Jan 27, 2022

FORM 8K  Jan 21, 2022

FORM 8-K Dec 16, 2021

Form 10-Q November 10,, 2021

FORM 8-K Aug 27, 2021

Form 10-Q August 12, 2021

Form 8-K July 22, 2021

Form 8-K June 11, 2021

Form 10-Q  May 14, 2021

Form 10-K March 30 2021

Form 10-Q November 16 2020

FORM 10-Q August 13 2020

FORM 8-K June 16 2020

FORM 10-Q AMENDMENT NO. 1 June 11 2020

FORM 10-Q June 10 2020

FORM 10-K/A May 12 2020

FORM 8-K May 11 2020

FORM 10-K May 1 2020

FORM 8-K March 30, 2020

Form DEF 14C March 4 2020

Form 8-K February 11, 2020

Form PRE 14C February 10, 2020

Form 10-Q November, 7 2019

8-K (September 27, 2019)

Form 10-Q ending June 30, 2019. 

Form 10-12g Amended

Form 10-12g Amended

Form 10-12g

10-Q Quarter Ending September 30, 2016  

10-Q Quarter Ending Jun 30, 2016  

10-Q Quarter Ending March 31, 2016

10-k Annual Report 2015

10-Q Quarter Ending September 30, 2015

10-Q Quarter Ending June 30, 2015

NT 10-Q(August 14, 2015)

10-Q Quarter Ending March 31, 2015

NT 10-Q (May 18, 2015)

8-K (April 23, 2015)

10-K Annual Report 2014

NT 10-K (March 31, 2015)

8-K (February 06, 2015)

10-Q (November 14, 2014)

10-Q (August 14, 2014)

8-K (July 15, 2014)

8-K (July 10, 2014)

8-K (May 23, 2014)

10-Q/A (May 20, 2014)

10-Q (May 20, 2014)

NT 10-Q (May 15, 2014)

10-K (April 14, 2014)

S-1A (January 10, 2014)

S-1 (November 29, 2013)

8-K (October 25, 2013)

3rd Quarter 10-Q (Quarter ended  September 30, 2013)

2nd Quarter 10-Q (Quarter ended June 30, 2013)

OTC Filings


Quarterly Report for Period ending: March 31, 2019.

Annual Report For the Period Ending: December 31st. 2018

10-Q  Quarter Ending September 30, 2018

10-Q Quarter Ending  June 30, 2018

10-Q Quarter ending March 31, 2018    

10-K Annual Report December 31, 2017  

10-Q Quarter Ending September 30, 2017  

10-Q Quarter Ending Jun 30, 2017 

10-Q Quarter Ending March 31, 2017

10-k Annual Report December 31, 2016  


Statements on this website and of the management or representatives of BioAdaptives Inc. (the “Company”) in connection therewith that relate to beliefs, plans, objectives, goals, expectations, anticipations, intentions and future financial condition, results of operations or business performance constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on management’s current expectations about future events. These statements can be identified by the fact that they do not relate strictly to historical or current facts, and by words such as “may,” “could,” “should,” “would,” “believe,” “expect,” “project,” “anticipate,” “estimate,” “intend,” “plan” or other similar words or expressions.

Any or all of the forward-looking statements on this website or made by management may turn out to be in accurate or wrong. This can occur as a result of inaccurate assumptions or as a consequence of significant known or unknown risks and uncertainties. The Company addresses these risks in the “Risk Factors” section of its filings with the SEC. Because of these risks and uncertainties, the Company’s actual results may differ materially from those that might be anticipated from its forward-looking statements. Therefore, you are cautioned not to place undue reliance on such forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

Also, in presenting this material and responding to inquiries in connection to future performance of the company, management may refer to results, projections, or performance measures that are not prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) as reported in the company’s SEC filings. You are advised that these results, projections, or performance measures are non-GAAP measures and are not intended to replace or as a substitute for results measured under GAAP but rather as a supplement to the GAAP reported results.

This website or alerts from our website do not constitute or form part of an offer to sell or issue or invitation to purchase or subscribe for any shares of the Company in any jurisdiction, and no part of this website shall form the basis of or be relied upon in connection with any contract or commitment. Specifically, this website with corporate overview does not constitute a “prospectus” within the meaning of the U.S. Securities Act of 1933, as amen



Search our shop